You are here

  • Home
  • Archive
  • Volume 90, Issue 8
  • Why are anogenital warts diagnoses decreasing in the UK: bivalent human papillomavirus (HPV) vaccine cross-protection or failure to examine?

Article info

Article menu
Download PDFPDF
Letter
Why are anogenital warts diagnoses decreasing in the UK: bivalent human papillomavirus (HPV) vaccine cross-protection or failure to examine?

Authors

  1. Correspondence to Dr Emily Clarke, Department of Genitourinary Medicine, Royal South Hants Hospital, Brintons Terrace, Southampton SO14 0YG, UK; emilyrclarke{at}doctors.org.uk
View Full Text

Citation

Clarke E, Board C, Patel N, et al
Why are anogenital warts diagnoses decreasing in the UK: bivalent human papillomavirus (HPV) vaccine cross-protection or failure to examine?
Sexually Transmitted Infections 2014;90:587.

Publication history

  • Received December 10, 2013
  • Revised March 18, 2014
  • Accepted March 23, 2014
  • First published November 13, 2014.
Online issue publication 
May 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions